ATLANTA (October 20, 2004) – Alimera Sciences Inc., a dynamic ophthalmic pharmaceutical company, today announced that it has entered into a co-promotion agreement with VISTAKON Pharmaceuticals, LLC to market Soothe™, Alimera Sciences’ recently launched emollient (lubricant) dry-eye drops.

ATLANTA (August 13, 2004) - Alimera Sciences Inc., a dynamic ophthalmic pharmaceutical company, today unveiled Soothe™ Emollient (lubricant) Eye Drops, the market's first multi-dose, emollient-based artificial tear product. Soothe offers over-the-counter relief to the 12 million Americans suffering from dry eye, a condition resulting from the body's inability to produce enough tears to keep the eye surface lubricated.

ATLANTA (July 21, 2004) - Alimera Sciences Inc., a new kind of ophthalmic pharmaceutical company, today announced its board of directors, which includes funding partner representatives and one of ophthalmology's most distinguished professionals.

ATLANTA (July 9, 2004) - Alimera Sciences Inc., a recently formed specialty pharmaceutical company focused on the ophthalmic industry, announced today that it has received $26.75 million in Series A financing. The funds will be used for acquisition and continued development of the company's ophthalmic pharmaceutical pipeline and for the commercialization of the company's over-the-counter ophthalmic products.